In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Lexeo Therapeutics Inc (NASDAQ: LXEO) was $8.66 for the day, up 4.09% from the previous closing price of $8.32. In other words, the price has increased by $4.09 from its previous closing price. On the day, 1.35 million shares were traded. LXEO stock price reached its highest trading level at $8.71 during the session, while it also had its lowest trading level at $8.3.
Ratios:
Our analysis of LXEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.40 and its Current Ratio is at 7.40. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on November 20, 2025, initiated with a Overweight rating and assigned the stock a target price of $19.
On October 15, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $30.
On July 31, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $20.Oppenheimer initiated its Outperform rating on July 31, 2025, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’25 when Townsend Richard Nolan sold 1,127 shares for $9.27 per share. The transaction valued at 10,447 led to the insider holds 240,991 shares of the business.
Adler Eric sold 615 shares of LXEO for $5,701 on Nov 18 ’25. The Chief Medical Officer now owns 72,646 shares after completing the transaction at $9.27 per share. On Nov 18 ’25, another insider, See Tai Sandi, who serves as the Chief Development Officer of the company, sold 386 shares for $9.27 each. As a result, the insider received 3,578 and left with 65,476 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXEO now has a Market Capitalization of 632070272 and an Enterprise Value of 517763264.
Stock Price History:
The Beta on a monthly basis for LXEO is 1.90, which has changed by 0.17514122 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, LXEO has reached a high of $10.38, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 0.77%, while the 200-Day Moving Average is calculated to be 72.43%.
Shares Statistics:
LXEO traded an average of 1.22M shares per day over the past three months and 1075830 shares per day over the past ten days. A total of 72.99M shares are outstanding, with a floating share count of 60.28M. Insiders hold about 17.40% of the company’s shares, while institutions hold 75.64% stake in the company. Shares short for LXEO as of 1763078400 were 5636938 with a Short Ratio of 4.62, compared to 1760486400 on 7315216. Therefore, it implies a Short% of Shares Outstanding of 5636938 and a Short% of Float of 8.2600005.
